CELYAD ONCOLOGY SA Proceeds From Issuing Shares
CELYAD ONCOLOGY SA reported Proceeds From Issuing Shares of -EUR 124.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-23.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssuingShares · last filed 2023-03-23
| Period end | Proceeds From Issuing Shares | Proceeds From Issuing Shares 6 month | Proceeds From Issuing Shares 12 month |
|---|---|---|---|
| 2022-12-31 | -124.00K EUR 20-F · filed 2023-03-23 | ||
| 2021-12-31 | 36.57M EUR 20-F · filed 2023-03-23 | ||
| 2021-06-30 | 7.62M EUR 6-K · filed 2021-08-04 | ||
| 2021-06-14 | 900.00K EUR 20-F · filed 2023-03-23 | ||
| 2021-05-21 | 900.00K EUR 20-F · filed 2023-03-23 | ||
| 2019-12-31 | 16.45M EUR 20-F · filed 2022-03-24 | ||
| 2019-06-30 | 0.00 EUR 6-K · filed 2020-08-07 | ||
| 2018-12-31 | 43.01M EUR 20-F · filed 2021-03-24 | ||
| 2018-06-30 | 43.01M EUR 6-K/A · filed 2019-09-05 | ||
| 2017-12-31 | 625.00K EUR 20-F · filed 2020-03-25 | ||
| 2015-12-31 | 109.15M EUR 20-F · filed 2018-04-06 |